查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041812

強度調控放射治療市場預測—按放射類型、應用、最終用戶和地區分類的全球分析—2034年

Intensity Modulated Radiation Therapy Market Forecasts to 2034 - Global Analysis By Radiation Type (Proton Radiation, Electron Radiation, Photon Radiation and Other Radiation Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球強度調控放射治療市場預計到 2026 年將達到 26.8 億美元，並在預測期內以 6.8% 的複合年成長率成長，到 2034 年達到 45.3 億美元。

強度調控放射治療）是一種精準的放射治療技術，它能夠從多個角度調節放射束的強度。這使得在向癌組織精準輸送高劑量輻射的同時，最大限度地減少對周圍健康組織的輻射暴露。與傳統放射治療相比，IMRT的高精度提高了治療效果並減少了副作用。

根據美國癌症協會估計，2022 年美國新增癌症病例約 190 萬例。

全球癌症發生率正在上升。

隨著全球癌症發生率持續飆升，對先進精準治療方法的需求日益成長。調強放射治療（IMRT）能夠精準傳遞放射劑量，同時最大限度地減少對周圍健康組織的損傷，正迅速成為腫瘤治療領域的關鍵技術。癌症類型的日益多樣化以及人口老化，凸顯了高效個人化治療方法的必要性。這一趨勢使得IMRT在綜合癌症治療中發揮主導作用，並在不斷發展的癌症治療領域確立了其不可或缺的地位。

高昂的醫療費用

IMRT（調強放射治療）技術先進，需要精確的放射劑量輸送、專用設備和熟練的醫護人員，這些都導致​​了其高昂的成本。這種經濟負擔可能會阻礙醫療機構和患者選擇該療法，尤其是在醫療預算有限或報銷體係不完全的地區。此外，成本方面的擔憂可能會導致人們更加關注更具成本效益的替代治療方法，從而進一步影響IMRT的市場佔有率。

與個人化醫療結合

透過根據患者的個別特徵（例如遺傳特徵和腫瘤譜）客製化治療方案，IMRT 的精準性和有效性得以提升。這種個人化方法能夠最佳化治療計劃，最大限度地減少副作用，並改善治療效果。這種協同作用與精準醫療的整體趨勢相契合，推動了以患者為中心、更具針對性的治療方法。 IMRT 與個人化醫療的無縫銜接不僅拓展了其應用範圍，更使其處於腫瘤治療領域的前沿，從而推動了市場需求和成長。

實施的複雜性

IMRT技術的複雜性要求醫療專業人員（包括放射腫瘤學家和醫學物理學家）接受專門培訓，這可能導致合格人員短缺。 IMRT相關的先進計劃和照射流程不僅需要先進的設備，還需要對治療計劃軟體有深入的了解。將IMRT整合到現有醫療體系中需要對基礎設施進行大量投資，並進行持續的教育訓練。此外，掌握IMRT技術的學習曲線可能會阻礙其快速和廣泛應用，尤其是在資源匱乏的地區和醫療資源不平衡的地區。

新冠疫情的影響：

新冠疫情對市場產生了重大影響。疫情危機擾亂了醫療服務，導致擇期手術（包括非緊急癌症治療）延期。資源重新分配和優先用於新冠相關護理，使得用於常規癌症治療的醫療機構捉襟見肘，影響了調強放射治療（IMRT）的部署。此外，疫情後的經濟挑戰和醫療預算限制可能會影響投資決策，並減緩市場成長。儘管面臨這些不利因素，但隨著醫療系統適應疫情後不斷變化的環境，IMRT在晚期癌症治療中的重要性仍在推動其復甦。

在預測期內，乳癌市場預計將成為最大的細分市場。

預計乳癌領域將迎來顯著成長。調強放射治療（IMRT）能夠精準地將射線束靶向乳腺腫瘤，最大限度地減少對周圍健康組織的照射。因此，與傳統放射治療相比，IMRT 能夠改善治療效果並減少副作用。乳癌IMRT 的需求成長主要源自於全球乳癌發生率的上升，以及人們對先進精準治療方法日益成長的偏好，這些方案有助於提高乳癌患者的治療效果和生活品質。

在預測期內，醫院產業預計將呈現最高的複合年成長率。

在預測期內，醫院領域預計將呈現最高的複合年成長率。這些醫療機構正在投資最先進的調強放射治療（IMRT）技術和基礎設施，以確保患者獲得先進的放射治療。醫院與放射腫瘤科醫師和放射技師緊密合作，提供精準且個人化的IMRT治療。在醫院環境中應用IMRT可提升癌症治療能力，實現標靶治療，並最大限度地減少副作用。作為關鍵相關人員，醫院正在為IMRT在整個醫療領域的推廣和應用做出重大貢獻。

市佔率最大的地區：

在整個預測期內，北美市場預計將繼續佔據顯著佔有率，這主要得益於其先進的醫療基礎設施、較高的癌症發病率以及活躍的研發活動。該地區完善的保險報銷體系和對技術創新的高度重視，推動了調強放射治療（IMRT）的廣泛應用。此外，醫療專業人員和患者對IMRT益處的認知不斷提高，也進一步鞏固了其市場地位。主要市場參與者和研究機構之間的合作，進一步強化了北美市場的地位，並確保該地區對IMRT解決方案的需求持續成長，以滿足不斷變化的癌症治療需求。

複合年成長率最高的地區：

亞太地區在香料蘭姆酒市場中扮演著至關重要的角色，預計在預測期內將呈現最高的複合年成長率，這主要得益於癌症發病率的上升、醫療基礎設施的進步以及人們對先進治療方案認知度的提高。中國、印度和日本等國家在這擴張過程中處於領先地位，這主要得益於癌症治療投入的增加。該地區龐大的患者群體，加上政府為改善癌症治療所做的努力，為調強放射治療（IMRT）的應用創造了有利條件。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球強度調控放射治療市場：依放射類型分類

  • 質子束療法
  • 電子束
  • 光子束
  • 碳離子束療法
  • 其他類型的輻射

第6章 全球強度調控放射治療

  • 攝護腺癌
  • 肺癌
  • 乳癌
  • 腦癌
  • 婦科癌症
  • 其他用途

第7章 全球強度調控放射治療市場：依最終用戶分類

  • 醫院
  • 獨立放射治療中心
  • 其他最終用戶

第8章 全球強度調控放射治療

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Accuray Incorporated
  • Brainlab AG
  • Varian Medical Systems, Inc
  • Elekta AB
  • Hitachi, Ltd.
  • IBA Worldwide
  • Koninklijke Philips NV
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Raysearch Laboratories
  • Siemens Healthineers AG
Product Code: SMRC24878

According to Stratistics MRC, the Global Intensity Modulated Radiation Therapy Market is accounted for $2.68 billion in 2026 and is expected to reach $4.53 billion by 2034 growing at a CAGR of 6.8% during the forecast period. Intensity Modulated Radiation Therapy (IMRT) is a precise radiotherapy technique that adjusts radiation beam intensity across multiple angles. This allows targeted delivery of higher doses to cancerous tissue while minimizing exposure to surrounding healthy structures. IMRT's precision enhances treatment effectiveness and reduces side effects compared to conventional radiation therapy.

According to the American Cancer Society, in 2022, an estimated 1.9 million new cases of cancer were diagnosed in the U.S.

Market Dynamics:

Driver:

The rising prevalence of cancer worldwide

Cancer rates continue to surge worldwide, there is a heightened demand for advanced and precise treatment modalities. IMRT, with its ability to deliver targeted radiation doses while minimizing damage to surrounding healthy tissues, have emerged as a crucial technology in the oncology landscape. The rising prevalence of diverse cancer types, coupled with an aging population, underscores the need for effective and tailored therapies. This trend propels the adoption of IMRT as a key player in the comprehensive oncological care, positioning it as a vital solution in the evolving landscape of cancer treatment.

Restraint:

High treatment costs

IMRT's sophisticated technology, involving precise radiation delivery, specialized equipment, and skilled personnel, contributes to elevated treatment expenses. This financial burden may deter healthcare institutions and patients, particularly in regions with limited healthcare budgets or where reimbursement policies are insufficient. The threat intensifies as cost considerations may divert attention toward alternative, more cost-effective treatment options, impacting IMRT's market share.

Opportunity:

Personalized medicine integration

Tailoring treatments to individual patient characteristics, such as genetic makeup and tumor profiles, enhances the precision and effectiveness of IMRT. Personalized approaches allow for optimized treatment plans, minimizing side effects and improving outcomes. This synergy aligns with the broader trend in healthcare towards precision medicine, fostering a more patient-centric and targeted therapeutic approach. The ability of IMRT to seamlessly integrate with personalized medicine not only expands its applicability but also positions it at the forefront of cutting-edge oncological care, driving demand and market growth.

Threat:

Complexity of implementation

IMRT's intricate technology demands specialized training for healthcare professionals, including radiation oncologists and medical physicists, leading to a potential shortage of adequately skilled personnel. The sophisticated planning and delivery processes involved in IMRT require not only advanced equipment but also a nuanced understanding of treatment planning software. Integration of IMRT into existing healthcare systems necessitates substantial investments in infrastructure and continuous educational initiatives. Moreover, the learning curve for mastering IMRT techniques may hinder its swift and widespread adoption, particularly in regions with limited resources or healthcare disparities.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the market. The crisis led to disruptions in healthcare services, delaying elective procedures, including non-urgent cancer treatments. Resource reallocation and prioritization of COVID-19-related care strained the availability of medical facilities for routine cancer therapies, affecting the adoption of IMRT. Moreover, economic challenges and healthcare budget constraints in the wake of the pandemic may have influenced investment decisions, potentially slowing down the market's growth. Despite these setbacks, the importance of IMRT in advanced cancer care continues to drive its recovery as healthcare systems adapt to the evolving post-pandemic landscape.

The breast cancer segment is expected to be the largest during the forecast period

The breast cancer segment is expected to have a lucrative growth. IMRT's precision in adjusting radiation beams allows for targeted delivery to breast tumors while minimizing exposure to surrounding healthy tissue. This results in enhanced treatment efficacy and reduced side effects compared to conventional radiation therapy. The demand for IMRT in breast cancer cases is driven by the rising incidence of breast cancer globally, coupled with the increasing preference for advanced and precise treatment modalities that contribute to improved outcomes and better quality of life for patients undergoing radiation therapy for breast cancer.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period. These healthcare institutions invest in state-of-the-art IMRT technology and infrastructure, ensuring access to advanced radiation therapies for patients. Hospitals collaborate with radiation oncologists and technologists to deliver precise and personalized IMRT treatments. The integration of IMRT within hospital settings enhances cancer care capabilities, allowing for targeted therapy delivery and minimizing side effects. As key stakeholders, hospitals contribute significantly to the growth and accessibility of IMRT in the broader healthcare landscape.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share, driven by advanced healthcare infrastructure, a high prevalence of cancer, and robust R&D activities. The region's well-established reimbursement policies and a strong focus on technological innovation contribute to widespread adoption. Moreover, increasing awareness about the benefits of IMRT among healthcare professionals and patients enhances its market presence. Collaboration between key market players and research institutions further solidifies North America's position, ensuring a continuous surge in demand for IMRT solutions to address the evolving needs of cancer treatment in the region.

Region with highest CAGR:

The Asia Pacific region plays a significant role in the spice rum market and is projected to have the highest CAGR over the forecast period driven by increasing cancer prevalence, advancing healthcare infrastructure, and rising awareness of advanced treatment options. Countries like China, India, and Japan are at the forefront of this expansion, with growing investments in oncology care. The region's large patient pool, coupled with government initiatives to improve cancer treatment, creates a fertile ground for IMRT adoption.

Key players in the market

Some of the key players in Intensity Modulated Radiation Therapy market include Accuray Incorporated, Brainlab AG, Varian Medical Systems, Inc, Elekta AB, Hitachi, Ltd., IBA Worldwide, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Raysearch Laboratories and Siemens Healthineers AG.

Key Developments:

In October 2023, Siemens Healthineers AG Partnered with RefleXion X to develop AI-powered solutions for optimizing IMRT treatment plans.

In June 2023, Elekta AB. acquired Monaco, a leading treatment planning software for IMRT and other modalities.

In November 2022, Accuray unveiled a strategic collaboration with Limbus AI to bolster adaptive radiotherapy solutions. This partnership marked a significant milestone in expanding Accuray's product portfolio, showcasing the company's commitment to advancing cutting-edge technologies in the field of radiotherapy.

Radiation Types Covered:

  • Proton Radiation
  • Electron Radiation
  • Photon Radiation
  • Carbon Ion Radiation
  • Other Radiation Types

Applications Covered:

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain Cancer
  • Gynecological Cancer
  • Other Applications

End Users Covered:

  • Hospitals
  • Standalone Radiation Therapy Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intensity Modulated Radiation Therapy Market, By Radiation Type

  • 5.1 Introduction
  • 5.2 Proton Radiation
  • 5.3 Electron Radiation
  • 5.4 Photon Radiation
  • 5.5 Carbon Ion Radiation
  • 5.6 Other Radiation Types

6 Global Intensity Modulated Radiation Therapy Market, By Application

  • 6.1 Introduction
  • 6.2 Prostate Cancer
  • 6.3 Lung Cancer
  • 6.4 Breast Cancer
  • 6.5 Brain Cancer
  • 6.6 Gynecological Cancer
  • 6.7 Other Applications

7 Global Intensity Modulated Radiation Therapy Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Standalone Radiation Therapy Centers
  • 7.4 Other End Users

8 Global Intensity Modulated Radiation Therapy Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Accuray Incorporated
  • 10.2 Brainlab AG
  • 10.3 Varian Medical Systems, Inc
  • 10.4 Elekta AB
  • 10.5 Hitachi, Ltd.
  • 10.6 IBA Worldwide
  • 10.7 Koninklijke Philips N.V.
  • 10.8 Mevion Medical Systems
  • 10.9 Mitsubishi Electric Corporation
  • 10.10 Raysearch Laboratories
  • 10.11 Siemens Healthineers AG

List of Tables

  • Table 1 Global Intensity Modulated Radiation Therapy Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 3 Global Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 4 Global Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 5 Global Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 6 Global Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 7 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 8 Global Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 9 Global Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 10 Global Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 11 Global Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 12 Global Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 13 Global Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 14 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 15 Global Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 16 Global Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 17 Global Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 18 Global Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 19 North America Intensity Modulated Radiation Therapy Market Outlook, By Country (2023-2034) ($MN)
  • Table 20 North America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 21 North America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 22 North America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 23 North America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 24 North America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 25 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 26 North America Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 27 North America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 28 North America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 29 North America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 30 North America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 31 North America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 32 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 33 North America Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 North America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 35 North America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 36 North America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 37 Europe Intensity Modulated Radiation Therapy Market Outlook, By Country (2023-2034) ($MN)
  • Table 38 Europe Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 39 Europe Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 40 Europe Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 41 Europe Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 42 Europe Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 43 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 44 Europe Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 45 Europe Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 46 Europe Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 47 Europe Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 48 Europe Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 49 Europe Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 50 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 51 Europe Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 52 Europe Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 53 Europe Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 54 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 55 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Country (2023-2034) ($MN)
  • Table 56 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 57 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 58 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 59 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 60 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 61 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 62 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 63 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 64 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 65 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 66 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 67 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 68 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 69 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 70 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 71 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 72 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 73 South America Intensity Modulated Radiation Therapy Market Outlook, By Country (2023-2034) ($MN)
  • Table 74 South America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 75 South America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 76 South America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 77 South America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 78 South America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 79 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 80 South America Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 81 South America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 82 South America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 83 South America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 84 South America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 85 South America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 86 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 87 South America Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 88 South America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 89 South America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 90 South America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 91 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Country (2023-2034) ($MN)
  • Table 92 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2023-2034) ($MN)
  • Table 93 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2023-2034) ($MN)
  • Table 94 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2023-2034) ($MN)
  • Table 95 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2023-2034) ($MN)
  • Table 96 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2023-2034) ($MN)
  • Table 97 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2023-2034) ($MN)
  • Table 98 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Application (2023-2034) ($MN)
  • Table 99 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 100 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 101 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 102 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2023-2034) ($MN)
  • Table 103 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2023-2034) ($MN)
  • Table 104 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 105 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By End User (2023-2034) ($MN)
  • Table 106 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 107 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2023-2034) ($MN)
  • Table 108 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2023-2034) ($MN)